In an essay published in International Journal of Drug Policy, Dutch psychology researcher Julian Heller and philosopher Yogi Hendlin argue that such attempts to take the trip out of psychedelics are a mistake.
The duo explain that psychedelics’ therapeutic potential is not merely neurochemical, but “highly dependent on subjective experience and environmental context.”
Read more
Inside the scientific debate that’s shaping the future of psychedelic therapy: To trip or not to trip?
Can the magic be removed from the mushroom — and should it?
Read more
Jules Evans of The Challenging Psychedelic Experiences Project discusses the project and what he and his co-researchers hope to learn from the data they collect.
Read more
Psychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read more
In the lab of Dr. Bryan Roth, experiments are underway to remove the powerful hallucinogenic effects from psychedelic drugs.
“There’s one receptor in the brain that psychedelics bind to,” he said, referring to the serotonin 5-HT-2A receptor. “What we’re trying to find is drugs that bind to that receptor (and) activate it, but don’t cause a psychedelic experience and are anti-depressant.”
Read more
Quisque iaculis facilisis lacinia. Mauris euismod pellentesque tellus sit amet mollis.